Picture of a kidney scan and text: Lupus Treatment that restores kidney function approved NICE has approved a treatment that restores normal kidney function in almost half of patients with lupus nephritis. Obinutuzumab (Gazyvaro) is a twice yearly intravenous infusion that, when combined with daily immunosuppressant tablets, "significantly outperforms" current treatments, said NICE. Around 60000 people in England and Wales have the autoimmune disease systemic lupus erythematosus, and as many as 60% of them will develop inflammation of the kidneys-lupus nephritis. The condition disproportionally affects women and people from Asian and black African or Caribbean backgrounds.
I’ve got a friend with lupus and I can see what an unpleasant condition it can be. So I was delighted to read about further advances in managing lupus nephritis, in today’s @bmj.com.
A twice yearly IV infusion doesn’t sound too burdensome too.
#MedSky
#Lupus
#KidneySky
#AutoImmune